| |
| |
|
| Insider
Information: |
Mast Erle T |
| Relationship: |
Director |
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
142,283 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,034 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
142,283 |
|
|
| Total
Value |
$2,034 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Welltek Incorporated |
WTKND |
EVP, CFO |
2008-03-07 |
0 |
|
0 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2013-03-06 |
0 |
2008-12-31 |
0 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
Director |
2022-03-07 |
0 |
2010-12-10 |
0 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
Executive VP and CFO |
2015-11-02 |
135,583 |
2011-11-21 |
0 |
Premium* |
|
|
Receptos, Inc. |
RCPT |
Director |
2015-08-27 |
0 |
2014-03-14 |
0 |
Premium* |
|
|
Sienna Biopharmaceuticals, Inc. |
SNNA |
Director |
2017-08-01 |
6,700 |
2017-08-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLVS |
Clovis Oncology, Inc. |
Executive VP and CFO |
• – – |
2015-08-03 |
4 |
AS |
$85.23 |
$257,921 |
D/D |
(3,000) |
144,583 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Executive VP and CFO |
• – – |
2015-06-01 |
4 |
AS |
$86.04 |
$266,326 |
D/D |
(3,000) |
150,583 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Executive VP and CFO |
• – – |
2015-10-01 |
4 |
AS |
$89.40 |
$270,657 |
D/D |
(3,000) |
138,583 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Executive VP and CFO |
• – – |
2015-11-02 |
4 |
AS |
$98.82 |
$316,679 |
D/D |
(3,000) |
135,583 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Executive VP and CFO |
• – – |
2015-03-09 |
4 |
AS |
$78.78 |
$709,554 |
D/D |
(9,000) |
159,583 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Executive VP and CFO |
• – – |
2013-12-11 |
4 |
S |
$51.64 |
$1,245,769 |
D/D |
(24,123) |
168,583 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Executive VP and CFO |
• – – |
2013-12-10 |
4 |
S |
$53.81 |
$1,392,988 |
D/D |
(25,877) |
192,706 |
0 |
- |
|
| WTKND |
Welltek Incorporated |
Sr. Vice President, Chief Fina |
– – – |
2007-08-06 |
144 |
NP |
$0.00 |
$2,100,000 |
/ |
50,000 |
0 |
|
- |
|
| WTKND |
Welltek Incorporated |
EVP, CFO |
• – – |
2007-08-06 |
4 |
S |
$42.00 |
$2,100,000 |
D/D |
(50,000) |
8,284 |
0 |
- |
|
59 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
